Results 171 to 180 of about 1,314 (191)

Treatment of Iluvien® malposition with YAG laser: A case study approach.

Journal Français d'Ophtalmologie, 2023
M. Rustullet-Olivé, R. Fernández-Hernández, D. Vilaplana-Blanch   +2 more
semanticscholar   +3 more sources

Intravitreal fluocinolone acetonide 0.19 mg (Iluvien) implant for radiation maculopathy.

Canadian Journal of Ophthalmology
Paul T. Finger, Shayri Pillai, A. Tomar
semanticscholar   +2 more sources

ILUVIEN® in diabetic macular edema that persists or recurs despite treatment: Results from the Retina.pt® RIVER audit

European Journal of Ophthalmology, 2023
Purpose Persistent diabetic macular edema (DME) remains a problem in clinical practice, with many patients having a suboptimal response to the standard of care (SOC).
Carla Teixeira, B. Pessoa, M. Ruão, João Paulo Castro Sousa, S. Penas, Rufino Silva, Ângela Carneiro, A. Meireles   +7 more
semanticscholar   +1 more source

Alternative technique for the injection of fluocinolone acetonide (FAc) intravitreal implant (Iluvien ® ) in case of leakage of its injector

European Journal of Ophthalmology, 2023
Purpose To show an alternative surgical technique for the introduction of the intravitreal fluocinolone acetonide (FAc) implant (Iluvien®) into the vitreous cavity using a 23-gauge (G) trocar if it is retained during its implantation in the ...
T. Diago, Silvia G Fau, Jaime Moya Roca
semanticscholar   +1 more source

Intraocular Suture of a Migrated ILUVIEN Implant into the Vitreous Cavity.

Ophthalmology Retina, 2020
F. Rommel, M. Ranjbar, S. Grisanti
semanticscholar   +3 more sources

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the treatment of ocular juvenile xanthogranuloma.

Archivos de la Sociedad Española de Oftalmología (English Edition)
M. Larrañaga Cores, M. Asencio Durán, J. Peralta Calvo, M. Feito Rodríguez, G. Amorena Santesteban, A. Del Hierro Zarzuelo, A. Boto-de-Los-Bueis   +6 more
semanticscholar   +2 more sources

Implante intravítreo de acetónido de fluocinolona (ILUVIEN®) para el tratamiento del xantogranuloma ocular juvenil

Archivos de la Sociedad Española de Oftalmología
M. Larrañaga Cores, M. Asencio Durán, J. Peralta Calvo, M. Feito Rodríguez, G. Amorena Santesteban, A. del Hierro Zarzuelo, A. Boto-de-los-Bueis   +6 more
semanticscholar   +2 more sources

Iluvien Implantation for Uveitis and Uveitic Macular Edema

Ocular Immunology and Inflammation, 2018
A. Reddy, Bryn M. Burkholder, Irfan R. Khan, J. Thorne   +3 more
semanticscholar   +3 more sources

OBSERVATION: FLUOCINOLONE ACETONIDE (ILUVIEN) IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER

RETINAL Cases & Brief Reports, 2017
Purpose: To describe the anterior chamber migration of a fluocinolone acetonide (Iluvien) implant in the context of previous vitrectomy and complicated cataract surgery. Methods: Retrospective observational case series.
V. Papastavrou, H. Zambarakji, I. Dooley, H. Eleftheriadis, Timothy L. Jackson   +4 more
semanticscholar   +4 more sources

Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema

Drugs, 2017
Fluocinolone acetonide intravitreal implant 0.19 mg (ILUVIEN®) is a nonbiodegradable, injectable, corticosteroid implant that is approved in several countries, including the USA, for the treatment of diabetic macular edema (DME). ILUVIEN® releases fluocinolone acetonide at an initial rate of 0.25 µg/day (average rate 0.2 µg/day) and lasts 36 months. In
Yahiya Y. Syed
semanticscholar   +3 more sources